Skip to main contentSkip to navigation
Sirius Investors
Eli Lilly and Company

Eli Lilly and Company

LLY
NYSEHealthcare

Revenue Analysis - LLY

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

LLY Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product

0.0% of total revenue

$18.5B

Cardiometabolic Health

0.0% of total revenue

$15.8B

Oncology

0.0% of total revenue

$2.3B

Collaboration and Other Revenue

0.0% of total revenue

$1.3B

Immunology

0.0% of total revenue

$1.2B

Neuroscience

0.0% of total revenue

$382.0M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Cardiometabolic Health
Collaboration and Other Revenue
Immunology
Neuroscience
Oncology
Other Product, Total
Product
3/31/2026$15.8B$1.3B$1.2B$382.0M$2.3B$0$18.5B
9/30/2025$13.2B$1.3B$1.4B$315.7M$2.4B$337.2M$16.3B
6/30/2025$11.3B$831.7M$1.3B$344.0M$2.4B$201.5M$14.7B
3/31/2025$9.2B$1.1B$1.1B$272.1M$1.9B$212.9M$11.6B
9/30/2024$7.4B$0$1.2B$469.0M$2.6B$262.8M$0
6/30/2024$7.5B$0$1.1B$487.0M$2.5B$207.6M$0

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Neuroscience+21.0%
Cardiometabolic Health+19.6%
Product+13.0%
Declining Segments
Immunology-11.7%

Geographic Regions

Growing Regions
CHINA+46.2%
Europe+17.7%
Declining Regions
Non-US-56.2%
JAPAN-12.7%

Earnings Reports

Want to see how LLY's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports